胰腺消炎汤灌肠治疗急性水肿型胰腺炎疗效观察

目的观察胰腺消炎汤灌肠治疗急性水肿型胰腺炎的效果。方法将水肿型胰腺炎患者随机分为2组,均使用抗生素、制酸、抑酶及支持治疗,治疗组加用自拟方胰腺消炎汤灌肠;观察2组症状及血清淀粉酶的变化。结果治疗组疗效及血清淀粉酶的改善均优于对照组。结论胰腺消炎汤灌肠辅助治疗急性水肿型胰腺炎疗效较好。

芒硝及清胰汤联合西药治疗急性重症胰腺炎的护理

急性胰腺炎是常见急腹症之一,是由胰酶激活后引起胰腺组织自身消化所致的急性化学性炎症,其病情程度轻重不一,主要表现为急性腹痛、恶心、呕吐,病情严重者重者可致胰腺出血、坏死并发休克或多器官功能衰竭的综合症候群,重症急性胰腺炎约占急性胰腺炎的5%-16%,死亡率较高.笔者统计自2014年1月至2016年6月,我科共23例急性重症胰腺炎患者采用了芒硝外敷与清胰汤联合西药非手术治疗,取得满意的效果,现将护理体会报道如下.

自拟胰腺消炎汤配合西药治疗轻症急性胰腺炎(肝郁气滞型)临床疗效观察

目的:观察采用自拟胰腺消炎汤配合西药治疗轻症急性胰腺炎(MAP)(肝郁气滞型)的临床疗效及预后影响。方法:选取2016年1月~2018年1月于我院诊治的80例肝郁气滞型MAP患者,随机分为观察组(n=40)和对照组(n=40),对照组采用西医治疗。观察组患者在对照组基础上配合自拟胰腺消炎汤治疗。治疗7天后,观察自拟胰腺消炎汤配合西药治疗肝郁气滞型MAP的疗效及预后。结果:观察组治疗后测得血清淀粉酶(AMS)水平值明显较对照组低(P<0.05),观察组患者腹痛腹胀缓解时间、AMS水平恢复正常时间和住院总时间均短于对照组(P<0.05),观察组患者治疗7天后总有效率明显较对照组高(P<0.05)。结论:自拟胰腺消炎汤配合西药治疗肝郁气滞型MAP有显著疗效,且预后良好,建议临床推广。

48例急性胰腺炎的治疗方法及疗效

目的:探讨急性胰腺炎的临床治疗方法及效果。方法:选择我院2009年1月至2011年1月治疗的急性胰腺炎患者48例。按病情程度将其分为两组,其中,治疗组24例,采用西医常规治疗、中医治疗及食物治疗等综合治疗方式;对照组24例,采取常规西医治疗。结果:治疗组治愈19例,3例好转,治愈率为79.16%,总有效率为91.66%;对照组治愈14例,4例好转,治愈率为58.33%,总有效率为75%。结论:常规治疗配合中医、食疗的综合治疗方式,能取得更好的治疗效果,与对照组相比,治疗组总有效率提高16%,治愈率提高20%左右,值得临床广泛应用。

西医配合中药灌肠治疗急性胰腺炎的临床应用

目的探讨西医配合中药灌肠治疗急性胰腺炎的临床价值,提高中西医结合治疗此病的疗效。方法将208例患者随机分为治疗组与对照组,每组各104例,对照组采用禁食、胃肠减压、抑制胰酶分泌、抗感染,配合输液维持水电解质平衡,适当加以营养、止痛等。治疗组在西药治疗的基础上,加自拟"胰腺炎汤"加减方灌肠,每日2次,每次100ml,7天为1个疗程,两组均治疗两个疗程。结果治疗组较对照组在症状体征消失时间上有明显差异。结论中药灌肠治疗急性胰腺炎缓解症状快,治疗时间短,疗效可靠,值得推广。

自拟胰腺消炎汤联合西药治疗急性胰腺炎临床疗效及不良反应观察

目的观察急性胰腺炎患者应用自拟胰腺消炎汤联合西药治疗的临床疗效及不良反应,为临床诊断治疗提供一定的参考价值。方法 78例急性胰腺炎患者随机分为两组。对照组采用西药治疗,治疗组在对照组基础上结合服用自拟胰腺腺炎汤治疗。结果治疗组治疗后总有效率显著高于对照组(P<0.05);治疗组腹痛缓解时间、血淀粉酶恢复正常时间均显著短于对照组(P<0.05);治疗组首次排便时间和治疗时间均显著短于对照组(P<0.05);两组均无明显不良反应。结论自拟胰腺消炎汤联合西药治疗急性胰腺炎临床疗效显著,且无明显不良反应,安全可靠。

Treatment of abdominal compartment syndrome in severe acute pancreatitis patients with traditional Chinese medicine

AIM: To investigate the therapeutic effect of traditional Chinese traditional medicines Da Cheng Qi Decoction (Timely-Purging and Yin-Preserving Decoction) and Glauber's salt combined with conservative measures on abdominal compartment syndrome (ACS) in severe acute pancreatitis (SAP) patients. METHODS: Eighty consecutive SAP patients, admitted for routine non-operative conservative treatment, were randomly divided into study group and control group (40 patients in each group). Patients in the study group received Da Cheng Qi Decoction enema for 2 h and external use of Glauber's salt, once a day for 7 d. Patients in the control group received normal saline (NS) enema. Routine non-operative conservative treatments included non-per os nutrition (NPON), gastrointestinal decompression, life support, total parenteral nutrition (TPN), continuous peripancreatic vascular pharmaceutical infusion and drug therapy. Intra-cystic pressure (ICP) of the two groups was measured during treatment. The effectiveness and outcomes of treatment were observed and APACHE Ⅱ scores were applied in analysis. RESULTS: On days 4 and 5 of treatment, the ICP was lower in the study group than in the control group(P < 0.05). On days 3-5 of treatment, acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ) scores for the study and control groups were significantly different (P < 0.05). Both the effectiveness and outcome of the treatment with Da Cheng Qi Decoction on abdominalgia, burbulence relief time, ascites quantity, cyst formation rate and hospitalization time were quite different between the two groups (P < 0.05). The mortality rate for the two groups had no significant difference. CONCLUSION: Da Cheng Qi Decoction enema and external use of Glauber's salt combined with routine non-operative conservative treatment can decrease the intra-abdominal pressure (IAP) of SAP patients and have preventive and therapeutic effects on abdominal compartment syndrome of SAP.

中西药联合治疗重症急性胰腺炎疗效观察

目的观察中西药联合治疗重症急性胰腺炎的临床疗效。方法64例重症胰腺炎患者随机分为治疗组（34例）和对照组（30例），两组均采用胰腺炎常规治疗，治疗组加用复方清胰汤或清胰陷胸汤治疗，观察比较两组临床疗效、平均住院时间及并发症发生情况。结果治疗组非手术治愈28例（82．4％），好转4例，死亡2例，平均住院时间（15．5±5．2）d，发生并发症5例（14．7％）；对照组非手术治愈19例（63．3％），好转7例，死亡4例，平均住院时间（19．6±5．2）d，发生并发症9例（30．0％）。两组治愈率、平均住院时间、并发症发生率等差异均有统计学意义（x^2=9．81，t=3．27、x^2=8．13，均P〈0．05）。结论中西药联合治疗重症急性胰腺炎能明显提高治愈率，减少并发症的发生，缩短住院时间。